Eli Lilly signs $1.9B gene-editing deal with Ascidian Therapeutics
Corroborated by 3 sources from 3 publishers
globalhealth2d ago
TL;DR
Reports differ across sources; according to finance.yahoo.com, eli Lilly signed a collaboration and licensing agreement with Boston-based Ascidian Therapeutics on Wednesday to research and develop treatments for inherited kidney diseases, with Ascidian eligible to receive up to $1.9 billion under the deal.
Sources
1
CNBC 10000108
https://www.cnbc.com/2026/06/03/eli-lilly-to-use-glp-1-windfall-to-fund-ma-and-diversify-pipeline.html
2d ago
2
Dow Jones WSJ
https://www.wsj.com/tech/biotech/eli-lilly-ascidian-sign-1-9-billion-kidney-disease-treatment-deal-94fefa90?mod=rss_Technology
2d ago
3
Yahoo Finance News
https://finance.yahoo.com/sectors/healthcare/articles/eli-lilly-signs-1-9b-140252071.html
2d ago